Autoimmune Diseases and Treatment
Organ-Specific and Systemic Disorders, Volume 1051
Herausgeber: Bragazzi, Nicola Luigi; Gershwin, M Eric
Autoimmune Diseases and Treatment
Organ-Specific and Systemic Disorders, Volume 1051
Herausgeber: Bragazzi, Nicola Luigi; Gershwin, M Eric
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Only in very recent times have therapies been developed that are specific to a particular manifestation of autoimmune disease, and these have begun to replace the all-purpose remedies of the past 30 years. This volume, which draws on the principles of immunology presented in Volume 1050 ( Autoimmunity: Concepts and Diagnosis at the Cutting Edge), extends these concepts to the realm of clinical findings and current therapy for many autoimmune and connective tissue disorders. Both organ-specific and organ-nonspecific diseases are covered, and one section is entirely focused on treatment.…mehr
- SHOENFELDAutoimmunity, Part a194,99 €
- ShoenfeldAutoimmunity, Part D204,99 €
- Apoptosis and the Immune System389,99 €
- The Year in Immunology 2008, Volume 1143194,99 €
- Autoimmunity422,99 €
- Kevin K BrownInterstitial Lung Diseases and Autoimmune Lung Diseases, an Issue of Immunology and Allergy Clinics117,99 €
- The Pulmonary Endothelium361,99 €
-
-
-
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
- Produktdetails
- Verlag: Wiley
- Seitenzahl: 828
- Erscheinungstermin: 1. September 2005
- Englisch
- Abmessung: 229mm x 152mm x 44mm
- Gewicht: 1175g
- ISBN-13: 9781573316132
- ISBN-10: 157331613X
- Artikelnr.: 23836746
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Wiley
- Seitenzahl: 828
- Erscheinungstermin: 1. September 2005
- Englisch
- Abmessung: 229mm x 152mm x 44mm
- Gewicht: 1175g
- ISBN-13: 9781573316132
- ISBN-10: 157331613X
- Artikelnr.: 23836746
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Apoptosis
and Clearance of Neutrophils in Wegener's Granulomatosis: André P. van Rossum
Pieter C. Limburg
and Cees G. M. Kallenberg. 2. Is PR3-ANCA Formation Initiated in Wegener's Granulomatosis Lesions? Granulomas as Potential Lymphoid Tissue Maintaining Autoantibody Production: J Voswinkel
A Müller
and P Lamprecht. 3. Clinical Relevance of Antiphospholipid Antibodies in Primary Biliary Cirrhosis: Philipp von Landenberg
Michael Baumgartner
Juergen Schoelmerich
Karl J. Lackner
and Reinhild Klein. 4. IL-10 and the Cytokine Network in the Pathogenesis of Human Autoimmune Hemolytic Anemia: Caterina Toriani-Terenzi and Enzo Fagiolo. 5. Crohn's Disease Is Associated with Polymorphism of CARD15/NOD2 Gene in a Hungarian Population: Zsuzsanna Nagy
Oszkár Karádi
György Rumi
György Rumi
Jr.
Alajos Pár
Gyula Mózsik
László Czirják
and Gábor Süto. 6. Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy: Esther Reefman
Pieter C. Limburg
Cees G. M. Kallenberg
and Marc Bijl. 7. Cancer-Associated Myositis: Clinical Features and Prognostic Signs: Andrea Ponyi
Tamás Constantin
Miklós Garami
Csilla andrás
Béla Tállai
Andrea Váncsa
Lajos Gergely
and Katalin Dankó. 8. Control of Type 1 Autoimmune Diabetes by Naturally Occurring CD4+CD25+ Regulatory T Lymphocytes in Neonatal NOD Mice: C A Piccirillo
M Tritt
E Sgouroudis
A Albanese
M Pyzik
and V Hay. 9. The Role of Methallothioneins in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Carmen Espejo and Eva M. Martínez-Cáceres. 10. Oxidized Low-Density Lipoprotein/ß2-Glycoprotein I Complexes and Autoantibodies in Patients with Type 2 Diabetes Mellitus: Luis R. Lopez
Beth L. Hurley
Daniel F. Simpson
and Eiji Matsuura. 11. Autoantibodies to Human 6 Integrin in Patients with Bullous Pemphigoid: Mária Kiss
Ádám Perényi
Ilona Marczinovits
János Molnár
Attila Dobozy
Lajos Kemény
and Sándor Husz. 12. Soluble HLA Class I and Class II Molecules in Relapsing-Remitting Multiple Sclerosis: Acute Response to Interferon-ß1a Treatment and Their Use as Markers of Disease Activity: Alireza Minagar
Irena Adamashvilli
Stephen L. Jaffe
Michael F. Glabus
Eduardo Gonzalez-Toledo
and Roger E. Kelley. 13. Proinflammatory Cytokines and Autoimmunity in Churg-Strauss Syndrome: B Hellmich
E Csernok
and W L Gross. 14. Rheumatic Fever: How S. pyogenes-Primed Peripheral T Cells Trigger Heart Valve Lesions: L Guilherme
K C Faé
S E Oshiro
A C Tanaka
P M A Pomerantzeff
and J Kalil. 15. Avidity of Anti-ß2-Glycoprotein I and Thrombosis or Pregnancy Loss in Patients with Antiphospholipid Syndrome: S Cucnik
B Bozic
T Kveder
M Tomsic
and B Rozman. 16. Neurological Complications of Celiac Disease and Autoimmune Mechanisms: Preliminary Data of a Prospective Study in Adult Patients: C Briani
G Zara
E Toffanin
S Ruggero
A Ferrarini
F De Lazzari
M Luca
D Faggian
F Grassivaro
M Ermani
R Pezzani
B Giometto
and A D'odorico. 17. E2F1-/- C57BL/6 Mice Overexpressing a Human Bcl-2 Transgene in B Cells Develop a Mild Autoimmune Syndrome: María J. Marín
Itxaso García
Marta Peña
Ainhoa Bolívar
Ana Zubiaga
and Marcos Lóez-Hoyos. 18. Systemic Thromboembolism in Inflammatory Bowel Disease: Mechanisms and Clinical Applications: Gilad Twig
Gisele Zandman-Goddard
Martine Szyper-Kravitz
and Yehuda Shoenfeld. 19. Pregnancy Loss and Endometriosis: Pathogenic Role of Anti-Laminin-1 Autoantibodies: Junko Inagaki
Akane Kondo
Luis R. Lopez
Yehuda Shoenfeld
and Eiji Matsuura. 20. Primary Biliary Cirrhosis: Solving the Enigma: Alessia Giorgini
Carlo Selmi
Pietro Invernizzi
Mauro Podda
Massimo Zuin
and M Eric Gershwin. 21. The Stages of Type 1A Diabetes: Naru Babaya
Maki Nakayama
and George S. Eisenbarth. 22. Soluble CD40L in Plasma of Patients with Primary Biliary Cirrhosis: Sabine Oertelt
Pietro Invernizzi
Carlo Selmi
Mauro Podda
and M Eric Gershwin. 23. Decreased Serum Leptin Levels in Primary Biliary Cirrhosis: A Link between Metabolism and Autoimmunity?: Roman Rieger
Sabine Oertelt
Carlo Selmi
Pietro Invernizzi
Mauro Podda
and M Eric Gershwin. 24. Analysis of the Foxp3/Scurfin Gene in Crohn's Disease: Ogyi Park
Irina Grishina
Patrick S. Leung
M Eric Gershwin
and T Prindiville. . Part II: Systematic Autoimmune Diseases:. 25. Juvenile Systemic Sclerosis: A Follow-up Study of Eight Patients: Szilvia Szamosi
László Maródi
László Czirják
Zoltán Ellenes
and Gabriella Szücs. 26. Antifodrin Antibodies in Sjögren's Syndrome: A Review: Torsten Witte. 27. Generation and Characterization of Three Monoclonal IgM Antiphospholipid Antibodies Recognizing Different Phospholipid Antigens: Catharina Buschmann
Christian Fischer
Viola Ochsenhirt
Carolin Neukirch
Karl J. Lackner
and Philipp von Landenberg. 28. Premature Immunosenescence in Rheumatoid Arthritis and Multiple Sclerosis Patients: Marielle Thewissen
Loes Linsen
Veerle Somers
Piet Geusens
Jef Raus
and Piet Stinissen. 29. Association of Rheumatoid Arthritis with HLA-DR1 and HLA-DR4 in Hungary: Anikó Kapitány
Erika Zilahi
Sándor Szántó
Gabriella Szücs
Zoltán Szabó
Anikó Végvári
Péter Rass
Sándor Sipka
Gyula Szegedi
and Zoltán Szekanecz. 30. Plasminogen Activator Inhibitor-1 Is Associated with Impaired Endothelial Function in Women with Systemic Lupus Erythematosus: Emily C. Somers
Wendy Marder
Mariana J. Kaplan
Robert D. Brook
and W Joseph McCune. 31. Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media: Roberto Gerli
Yaniv Sherer
Gaetano Vaudo
Giuseppe Schillaci
Boris Gilburd
andrea Giordano
Elena Bartoloni Bocci
Rosita Allegrucci
Simona Marchesi
Elmo Mannarino
and Yehuda Shoenfeld. 32. Investigation of Arthritic Joint Destruction by a Novel Fibroblast-Based Model: U Sack
B Sehm
F Kahlenberg
A Murr
J Lehmann
A Tannapfel
K Uberla
A Moessner
A Dietrich
F Emmrich
F Lange
A Jungel
J-M Braun
and U Anderegg. 33. Prevalence of Antiphospholipid and Antioxidized Low-Density Lipoprotein Antibodies in Rheumatoid Arthritis: Yaniv Sherer
Roberto Gerli
Gaetano Vaudo
Giuseppe Schillaci
Boris Gilburd
andrea Giordano
Elena Bartoloni Bocci
Rosita Allegrucci
Simona Marchesi
Elmo Mannarino
and Yehuda Shoenfeld. 34. Mono-organic versus Multi-organic Involvement in Primary Antiphospholipid Syndrome: Gabriela Medina
Olga Vera-Lastra
Ulises Angeles
and Luis J. Jara. 35. OxLDL/ß2GPI Complexes and Autoantibodies in Patients with Systemic Lupus Erythematosus
Systemic Sclerosis
and Antiphospholipid Syndrome: Pathogenic Implications for Vascular Involvement: Luis R. Lopez
Daniel F. Simpson
Beth L. Hurley
and Eiji Matsuura. 36. Anti-HSP60 Immunity Is Already Associated with Atherosclerosis Early in Life: M Knoflach
D Bernhard
and G Wick. 37. Determinants of Vessel Targeting in Vasculitis: Gary S. Hoffman. 38. Lymphocyte Activation as a Possible Measure of Atherosclerotic Risk in Patients with Sleep Apnea: Larissa Dyugovskaya
Peretz Lavie
and Lena Lavie. 39. Systemic Lupus Erythematosus
Atherosclerosis
and Autoantibodies: Sandra Zampieri
Luca Iaccarino
Anna Ghirardello
Elena Tarricone
Silvia Arienti
Piercarlo Sarzi-Puttini
Pierfranca Gambari
and andrea Doria. 40. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases: Karina de Leeuw
Cees Kallenberg
and Marc Bijl. 41. Nocturnal Hormones and Clinical Rhythms in Rheumatoid Arthritis: Maurizio Cutolo
Kati Otsa
Oivi Aakre
and Alberto Sulli. 42. Xenobiotic-Induced Recruitment of Autoantigens to Nuclear Proteasomes Suggests a Role for Altered Antigen Processing in Scleroderma: Min Chen and Anna von Mikecz. 43. Humoral Antigenic Targets of the Ribosomal P0 Lupus Autoantigen Are Not Limited to the Carboxyl Region: Benjamin F. Bruner
Donny M. Wynn
Morris Reichlin
John B. Harley
and Judith A. James. 44. Clinical Correlations of Potential Activity Markers in Systemic Sclerosis: R Becvár
J Stork
V Pesáková
A Stánová
H Hulejová
L Rysová
A Zatloukalová
P Zatloukal
M Jáchymová
and L Pourová. 45. Complement Activation: A Novel Pathogenic Mechanism in the Antiphospholipid Syndrome: Silvia S. Pierangeli
Mariano Vega-Ostertag
Xiaowei Liu
and Guillermina Girardi. 46. The Interplay of Chemokines and Dendritic Cells in the Pathogenesis of Lupus Nephritis: Marco Tucci
Nicola Calvani
Hanno B. Richards
Cosima Quatraro
and Franco Silvestris. 47. Cellular and Molecular Mechanisms of Regulation of Autoantibody Production in Lupus: Bevra H. Hahn
Fanny Ebling
Ram R. Singh
Ram P. Singh
George Karpouzas
and Antonio La Cava. 48. The Role of Innate and Adaptive Immunity to Oxidized Low-Density Lipoprotein in the Development of Atherosclerosis: Kazuko Kobayashi
Luis R. Lopez
Yehuda Shoenfeld
and Eiji Matsuura. 49. Predictive Markers for Development of Severe Organ Involvement in Patients with Systemic Sclerosis: Laure Ysebrant De Lendonck
Annick Ocmant
Florence Roufosse
and Elie Cogan. 50. Hughes Syndrome
the Antiphospholipid Syndrome: A New Chapter in Neurology: Giovanni Sanna
Maria Laura Bertolaccini
and Graham R. V. Hughes. 51. New Facet of Antiphospholipid Antibodies: Guido Valesini and Cristiano Alessandri. . Part III: Treatment:. 52. Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates: CH von Auer
J Oldenburg
M von Depka
C Escuriola-Ettinghausen
K Kurnik
H Lenk
and I Scharrer. 53. Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab: E Toubi
A Kessel
Z Mahmudov
K Hallas
M Rozenbaum
and I Rosner. 54. Synergistic Effect of Avemar on Proinflammatory Cytokine Production and Ras-Mediated Cell Activation: András Telekes
Endre Kiss-Tóth
Tünde Nagy
Eva E. Qwarnstrom
Erzsébet Kúsz
Timea Polgár
Ákos Resetár
Steven K. Dower
and Erno Duda. 55. Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases: Laszlo G. Boros
Michele Nichelatti
and Yehuda Shoenfeld. 56. Open-Label 24-Month Study Evaluating Infliximab Therapy in Patients with Psoriatic Spondyloarthropathy: J J Scali
A Kaminsky
J Salomón
S Visentini
and E Dancziger. 57. Cyclosporine: From Renal Transplantation to Autoimmune Diseases: Claudio Ponticelli. 58. Autoimmunity and Anti-TNF- Agents: Fabiola Atzeni
Maurizio Turiel
Franco Capsoni
andrea Doria
Pierluigi Meroni
and Piercarlo Sarzi-Puttini. 59. Combination Treatment of Rat Adjuvant-Induced Arthritis with Methotrexate
Probiotic Bacteria Enterococcus faecium
and Selenium: Jozef Rovensky
Karol Svík
Vladimír Matha
Richard Istok
Vojtech Kamarád
Libor Ebringer
Miroslav Ferencík
and Mária Stancíková. 60. Comparative Analysis of Antigen Specificities in the Monomeric and Dimeric Fractions of Intravenous Immunoglobulin: Sylvia M. Miescher
Alexander Schaub
Marco Ghielmetti
Michael Baumann
Monique Vogel
Reinhard Bolli
and Beda Stadler. 61. Treatment of Pemphigus Vulgaris with Protein A Immunoadsorption: Case Report of Long-Term History Showing Favorable Outcome: Nina Frost
Gerald Messer
Gerhard Fierlbeck
Teut Risler
and Simon D. Lytton. 62. Immunosuppressive Therapy and Clinical Evolution in Forty-nine Patients with Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis: E Kokolina
E Alexopoulos
C Dimitriadis
A Vainas
P Giamalis
A Papagianni
D Ekonomidou
and D Memmos. 63. Management of Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Pregnancy: Guillermo Ruiz-Irastorza and Munther A. Khamashta. 64. Gene-Gun Biolistic Immunization Encoding Glutamic Acid Decarboxylase: A Model for Studying Langerhans Cell Abnormalities and Mimicry in the Nonobese Diabetic Mouse: Béatrice Joussemet
Anh-Tuan Vu
Pierre Sai
and Jean-Marie Bach. 65. Intra-bone Marrow-Bone Marrow Transplantation: A New Strategy for Treatment of Stem Cell Disorders: Susumu Ikehara. 66. Removal of Pathogenic Autoantibodies by Immunoadsorption: Alon Y. Hershko and Yaakov Naparstek. 67. Chemokine Receptors: Attractive Targets for Drug Discovery: Nuria Godessart. 68. Rationale for T Cell Inhibition by Cyclosporin A in Major Autoimmune Diseases: G F Ferraccioli
P Tomietto
and M De Santis. 69. Partial Response to Anti-CD20 Monoclonal Antibody Treatment of Severe Immune Thrombocytopenic Purpura in a Patient with Common Variable Immunodeficiency: J Carbone
A Escudero
M Mayayo
M Ballesteros
A Perez-Corral
S Sanchez-Ramon
E Sarmiento
D Micheloud
and E Fernandez-Cruz. 70. CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases: Federico Perosa
Elvira Favoino
Maria Antonietta Caragnano
and Franco Dammacco. 71. Anticytokine Therapy
Especially Anti-Interferon-
as a Pathogenetic Treatment in TH-1 Autoimmune Diseases: Simon Skurkovich and Boris Skurkovich. 72. Therapeutic T Cell-Based Vaccination for Neurodegenerative Disorders: The Role of CD4+CD25+ Regulatory T Cells: Michal Schwartz and Jonathan Kipnis. 73. Tumor Necrosis Factor Inhibitor Therapy for Rheumatoid Arthritis: Stanley M. Naguwa. 74. Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines: Jochen Zwerina
Kurt Redlich
Georg Schett
and Josef S. Smolen. 75. Anti-inflammatory and Immune Regulatory Properties of 5-androsten-3ß
17ß-Diol (HE2100)
and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases: D Auci
F Nicoletti
K Mangano
R Pieters
S Nierkens
L Morgan
H Offner
J Frincke
and C Reading. 76. Immunomodulatory Effects of Intravenous Immunoglobulins as a Treatment for Autoimmune Diseases
Cancer
and Recurrent Pregnancy Loss: Tal Sapir
Miri Blank
and Yehuda Shoenfeld. 77. Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin: Yair Levy
Yosef Uziel
Giesele Zandman
Pnina Rotman
Hawared Amital
Yaniv Sherer
Pnina Langevitz
Boleck Goldman
and Yehuda Shoenfeld. 78. Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases: Helena Tlaskalová-Hogenová
Ludmila Tucková
Renata Stepánková
Tomás Hudcovic
Lenka Palová-Jelínková
Hana Kozáková
Pavel Rossmann
Daniel Sanchez
Jana Cinová
Tomás Hrncír
Miloslav Kverka
Lenka Frolová
Holm Uhlig
Fiona Powrie
and Paul Bland. 79. Do We Need New Treatment That Goes beyond Tumor Necrosis Factor Blockers for Rheumatoid Arthritis?: Reinhard E. Voll and Joachim R. Kalden
Apoptosis
and Clearance of Neutrophils in Wegener's Granulomatosis: André P. van Rossum
Pieter C. Limburg
and Cees G. M. Kallenberg. 2. Is PR3-ANCA Formation Initiated in Wegener's Granulomatosis Lesions? Granulomas as Potential Lymphoid Tissue Maintaining Autoantibody Production: J Voswinkel
A Müller
and P Lamprecht. 3. Clinical Relevance of Antiphospholipid Antibodies in Primary Biliary Cirrhosis: Philipp von Landenberg
Michael Baumgartner
Juergen Schoelmerich
Karl J. Lackner
and Reinhild Klein. 4. IL-10 and the Cytokine Network in the Pathogenesis of Human Autoimmune Hemolytic Anemia: Caterina Toriani-Terenzi and Enzo Fagiolo. 5. Crohn's Disease Is Associated with Polymorphism of CARD15/NOD2 Gene in a Hungarian Population: Zsuzsanna Nagy
Oszkár Karádi
György Rumi
György Rumi
Jr.
Alajos Pár
Gyula Mózsik
László Czirják
and Gábor Süto. 6. Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy: Esther Reefman
Pieter C. Limburg
Cees G. M. Kallenberg
and Marc Bijl. 7. Cancer-Associated Myositis: Clinical Features and Prognostic Signs: Andrea Ponyi
Tamás Constantin
Miklós Garami
Csilla andrás
Béla Tállai
Andrea Váncsa
Lajos Gergely
and Katalin Dankó. 8. Control of Type 1 Autoimmune Diabetes by Naturally Occurring CD4+CD25+ Regulatory T Lymphocytes in Neonatal NOD Mice: C A Piccirillo
M Tritt
E Sgouroudis
A Albanese
M Pyzik
and V Hay. 9. The Role of Methallothioneins in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Carmen Espejo and Eva M. Martínez-Cáceres. 10. Oxidized Low-Density Lipoprotein/ß2-Glycoprotein I Complexes and Autoantibodies in Patients with Type 2 Diabetes Mellitus: Luis R. Lopez
Beth L. Hurley
Daniel F. Simpson
and Eiji Matsuura. 11. Autoantibodies to Human 6 Integrin in Patients with Bullous Pemphigoid: Mária Kiss
Ádám Perényi
Ilona Marczinovits
János Molnár
Attila Dobozy
Lajos Kemény
and Sándor Husz. 12. Soluble HLA Class I and Class II Molecules in Relapsing-Remitting Multiple Sclerosis: Acute Response to Interferon-ß1a Treatment and Their Use as Markers of Disease Activity: Alireza Minagar
Irena Adamashvilli
Stephen L. Jaffe
Michael F. Glabus
Eduardo Gonzalez-Toledo
and Roger E. Kelley. 13. Proinflammatory Cytokines and Autoimmunity in Churg-Strauss Syndrome: B Hellmich
E Csernok
and W L Gross. 14. Rheumatic Fever: How S. pyogenes-Primed Peripheral T Cells Trigger Heart Valve Lesions: L Guilherme
K C Faé
S E Oshiro
A C Tanaka
P M A Pomerantzeff
and J Kalil. 15. Avidity of Anti-ß2-Glycoprotein I and Thrombosis or Pregnancy Loss in Patients with Antiphospholipid Syndrome: S Cucnik
B Bozic
T Kveder
M Tomsic
and B Rozman. 16. Neurological Complications of Celiac Disease and Autoimmune Mechanisms: Preliminary Data of a Prospective Study in Adult Patients: C Briani
G Zara
E Toffanin
S Ruggero
A Ferrarini
F De Lazzari
M Luca
D Faggian
F Grassivaro
M Ermani
R Pezzani
B Giometto
and A D'odorico. 17. E2F1-/- C57BL/6 Mice Overexpressing a Human Bcl-2 Transgene in B Cells Develop a Mild Autoimmune Syndrome: María J. Marín
Itxaso García
Marta Peña
Ainhoa Bolívar
Ana Zubiaga
and Marcos Lóez-Hoyos. 18. Systemic Thromboembolism in Inflammatory Bowel Disease: Mechanisms and Clinical Applications: Gilad Twig
Gisele Zandman-Goddard
Martine Szyper-Kravitz
and Yehuda Shoenfeld. 19. Pregnancy Loss and Endometriosis: Pathogenic Role of Anti-Laminin-1 Autoantibodies: Junko Inagaki
Akane Kondo
Luis R. Lopez
Yehuda Shoenfeld
and Eiji Matsuura. 20. Primary Biliary Cirrhosis: Solving the Enigma: Alessia Giorgini
Carlo Selmi
Pietro Invernizzi
Mauro Podda
Massimo Zuin
and M Eric Gershwin. 21. The Stages of Type 1A Diabetes: Naru Babaya
Maki Nakayama
and George S. Eisenbarth. 22. Soluble CD40L in Plasma of Patients with Primary Biliary Cirrhosis: Sabine Oertelt
Pietro Invernizzi
Carlo Selmi
Mauro Podda
and M Eric Gershwin. 23. Decreased Serum Leptin Levels in Primary Biliary Cirrhosis: A Link between Metabolism and Autoimmunity?: Roman Rieger
Sabine Oertelt
Carlo Selmi
Pietro Invernizzi
Mauro Podda
and M Eric Gershwin. 24. Analysis of the Foxp3/Scurfin Gene in Crohn's Disease: Ogyi Park
Irina Grishina
Patrick S. Leung
M Eric Gershwin
and T Prindiville. . Part II: Systematic Autoimmune Diseases:. 25. Juvenile Systemic Sclerosis: A Follow-up Study of Eight Patients: Szilvia Szamosi
László Maródi
László Czirják
Zoltán Ellenes
and Gabriella Szücs. 26. Antifodrin Antibodies in Sjögren's Syndrome: A Review: Torsten Witte. 27. Generation and Characterization of Three Monoclonal IgM Antiphospholipid Antibodies Recognizing Different Phospholipid Antigens: Catharina Buschmann
Christian Fischer
Viola Ochsenhirt
Carolin Neukirch
Karl J. Lackner
and Philipp von Landenberg. 28. Premature Immunosenescence in Rheumatoid Arthritis and Multiple Sclerosis Patients: Marielle Thewissen
Loes Linsen
Veerle Somers
Piet Geusens
Jef Raus
and Piet Stinissen. 29. Association of Rheumatoid Arthritis with HLA-DR1 and HLA-DR4 in Hungary: Anikó Kapitány
Erika Zilahi
Sándor Szántó
Gabriella Szücs
Zoltán Szabó
Anikó Végvári
Péter Rass
Sándor Sipka
Gyula Szegedi
and Zoltán Szekanecz. 30. Plasminogen Activator Inhibitor-1 Is Associated with Impaired Endothelial Function in Women with Systemic Lupus Erythematosus: Emily C. Somers
Wendy Marder
Mariana J. Kaplan
Robert D. Brook
and W Joseph McCune. 31. Early Atherosclerosis in Rheumatoid Arthritis: Effects of Smoking on Thickness of the Carotid Artery Intima Media: Roberto Gerli
Yaniv Sherer
Gaetano Vaudo
Giuseppe Schillaci
Boris Gilburd
andrea Giordano
Elena Bartoloni Bocci
Rosita Allegrucci
Simona Marchesi
Elmo Mannarino
and Yehuda Shoenfeld. 32. Investigation of Arthritic Joint Destruction by a Novel Fibroblast-Based Model: U Sack
B Sehm
F Kahlenberg
A Murr
J Lehmann
A Tannapfel
K Uberla
A Moessner
A Dietrich
F Emmrich
F Lange
A Jungel
J-M Braun
and U Anderegg. 33. Prevalence of Antiphospholipid and Antioxidized Low-Density Lipoprotein Antibodies in Rheumatoid Arthritis: Yaniv Sherer
Roberto Gerli
Gaetano Vaudo
Giuseppe Schillaci
Boris Gilburd
andrea Giordano
Elena Bartoloni Bocci
Rosita Allegrucci
Simona Marchesi
Elmo Mannarino
and Yehuda Shoenfeld. 34. Mono-organic versus Multi-organic Involvement in Primary Antiphospholipid Syndrome: Gabriela Medina
Olga Vera-Lastra
Ulises Angeles
and Luis J. Jara. 35. OxLDL/ß2GPI Complexes and Autoantibodies in Patients with Systemic Lupus Erythematosus
Systemic Sclerosis
and Antiphospholipid Syndrome: Pathogenic Implications for Vascular Involvement: Luis R. Lopez
Daniel F. Simpson
Beth L. Hurley
and Eiji Matsuura. 36. Anti-HSP60 Immunity Is Already Associated with Atherosclerosis Early in Life: M Knoflach
D Bernhard
and G Wick. 37. Determinants of Vessel Targeting in Vasculitis: Gary S. Hoffman. 38. Lymphocyte Activation as a Possible Measure of Atherosclerotic Risk in Patients with Sleep Apnea: Larissa Dyugovskaya
Peretz Lavie
and Lena Lavie. 39. Systemic Lupus Erythematosus
Atherosclerosis
and Autoantibodies: Sandra Zampieri
Luca Iaccarino
Anna Ghirardello
Elena Tarricone
Silvia Arienti
Piercarlo Sarzi-Puttini
Pierfranca Gambari
and andrea Doria. 40. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases: Karina de Leeuw
Cees Kallenberg
and Marc Bijl. 41. Nocturnal Hormones and Clinical Rhythms in Rheumatoid Arthritis: Maurizio Cutolo
Kati Otsa
Oivi Aakre
and Alberto Sulli. 42. Xenobiotic-Induced Recruitment of Autoantigens to Nuclear Proteasomes Suggests a Role for Altered Antigen Processing in Scleroderma: Min Chen and Anna von Mikecz. 43. Humoral Antigenic Targets of the Ribosomal P0 Lupus Autoantigen Are Not Limited to the Carboxyl Region: Benjamin F. Bruner
Donny M. Wynn
Morris Reichlin
John B. Harley
and Judith A. James. 44. Clinical Correlations of Potential Activity Markers in Systemic Sclerosis: R Becvár
J Stork
V Pesáková
A Stánová
H Hulejová
L Rysová
A Zatloukalová
P Zatloukal
M Jáchymová
and L Pourová. 45. Complement Activation: A Novel Pathogenic Mechanism in the Antiphospholipid Syndrome: Silvia S. Pierangeli
Mariano Vega-Ostertag
Xiaowei Liu
and Guillermina Girardi. 46. The Interplay of Chemokines and Dendritic Cells in the Pathogenesis of Lupus Nephritis: Marco Tucci
Nicola Calvani
Hanno B. Richards
Cosima Quatraro
and Franco Silvestris. 47. Cellular and Molecular Mechanisms of Regulation of Autoantibody Production in Lupus: Bevra H. Hahn
Fanny Ebling
Ram R. Singh
Ram P. Singh
George Karpouzas
and Antonio La Cava. 48. The Role of Innate and Adaptive Immunity to Oxidized Low-Density Lipoprotein in the Development of Atherosclerosis: Kazuko Kobayashi
Luis R. Lopez
Yehuda Shoenfeld
and Eiji Matsuura. 49. Predictive Markers for Development of Severe Organ Involvement in Patients with Systemic Sclerosis: Laure Ysebrant De Lendonck
Annick Ocmant
Florence Roufosse
and Elie Cogan. 50. Hughes Syndrome
the Antiphospholipid Syndrome: A New Chapter in Neurology: Giovanni Sanna
Maria Laura Bertolaccini
and Graham R. V. Hughes. 51. New Facet of Antiphospholipid Antibodies: Guido Valesini and Cristiano Alessandri. . Part III: Treatment:. 52. Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates: CH von Auer
J Oldenburg
M von Depka
C Escuriola-Ettinghausen
K Kurnik
H Lenk
and I Scharrer. 53. Increased Spontaneous Apoptosis of CD4+CD25+ T Cells in Patients with Active Rheumatoid Arthritis Is Reduced by Infliximab: E Toubi
A Kessel
Z Mahmudov
K Hallas
M Rozenbaum
and I Rosner. 54. Synergistic Effect of Avemar on Proinflammatory Cytokine Production and Ras-Mediated Cell Activation: András Telekes
Endre Kiss-Tóth
Tünde Nagy
Eva E. Qwarnstrom
Erzsébet Kúsz
Timea Polgár
Ákos Resetár
Steven K. Dower
and Erno Duda. 55. Fermented Wheat Germ Extract (Avemar) in the Treatment of Cancer and Autoimmune Diseases: Laszlo G. Boros
Michele Nichelatti
and Yehuda Shoenfeld. 56. Open-Label 24-Month Study Evaluating Infliximab Therapy in Patients with Psoriatic Spondyloarthropathy: J J Scali
A Kaminsky
J Salomón
S Visentini
and E Dancziger. 57. Cyclosporine: From Renal Transplantation to Autoimmune Diseases: Claudio Ponticelli. 58. Autoimmunity and Anti-TNF- Agents: Fabiola Atzeni
Maurizio Turiel
Franco Capsoni
andrea Doria
Pierluigi Meroni
and Piercarlo Sarzi-Puttini. 59. Combination Treatment of Rat Adjuvant-Induced Arthritis with Methotrexate
Probiotic Bacteria Enterococcus faecium
and Selenium: Jozef Rovensky
Karol Svík
Vladimír Matha
Richard Istok
Vojtech Kamarád
Libor Ebringer
Miroslav Ferencík
and Mária Stancíková. 60. Comparative Analysis of Antigen Specificities in the Monomeric and Dimeric Fractions of Intravenous Immunoglobulin: Sylvia M. Miescher
Alexander Schaub
Marco Ghielmetti
Michael Baumann
Monique Vogel
Reinhard Bolli
and Beda Stadler. 61. Treatment of Pemphigus Vulgaris with Protein A Immunoadsorption: Case Report of Long-Term History Showing Favorable Outcome: Nina Frost
Gerald Messer
Gerhard Fierlbeck
Teut Risler
and Simon D. Lytton. 62. Immunosuppressive Therapy and Clinical Evolution in Forty-nine Patients with Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis: E Kokolina
E Alexopoulos
C Dimitriadis
A Vainas
P Giamalis
A Papagianni
D Ekonomidou
and D Memmos. 63. Management of Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Pregnancy: Guillermo Ruiz-Irastorza and Munther A. Khamashta. 64. Gene-Gun Biolistic Immunization Encoding Glutamic Acid Decarboxylase: A Model for Studying Langerhans Cell Abnormalities and Mimicry in the Nonobese Diabetic Mouse: Béatrice Joussemet
Anh-Tuan Vu
Pierre Sai
and Jean-Marie Bach. 65. Intra-bone Marrow-Bone Marrow Transplantation: A New Strategy for Treatment of Stem Cell Disorders: Susumu Ikehara. 66. Removal of Pathogenic Autoantibodies by Immunoadsorption: Alon Y. Hershko and Yaakov Naparstek. 67. Chemokine Receptors: Attractive Targets for Drug Discovery: Nuria Godessart. 68. Rationale for T Cell Inhibition by Cyclosporin A in Major Autoimmune Diseases: G F Ferraccioli
P Tomietto
and M De Santis. 69. Partial Response to Anti-CD20 Monoclonal Antibody Treatment of Severe Immune Thrombocytopenic Purpura in a Patient with Common Variable Immunodeficiency: J Carbone
A Escudero
M Mayayo
M Ballesteros
A Perez-Corral
S Sanchez-Ramon
E Sarmiento
D Micheloud
and E Fernandez-Cruz. 70. CD20 Mimicry by a mAb Rituximab-Specific Linear Peptide: A Potential Tool for Active Immunotherapy of Autoimmune Diseases: Federico Perosa
Elvira Favoino
Maria Antonietta Caragnano
and Franco Dammacco. 71. Anticytokine Therapy
Especially Anti-Interferon-
as a Pathogenetic Treatment in TH-1 Autoimmune Diseases: Simon Skurkovich and Boris Skurkovich. 72. Therapeutic T Cell-Based Vaccination for Neurodegenerative Disorders: The Role of CD4+CD25+ Regulatory T Cells: Michal Schwartz and Jonathan Kipnis. 73. Tumor Necrosis Factor Inhibitor Therapy for Rheumatoid Arthritis: Stanley M. Naguwa. 74. Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines: Jochen Zwerina
Kurt Redlich
Georg Schett
and Josef S. Smolen. 75. Anti-inflammatory and Immune Regulatory Properties of 5-androsten-3ß
17ß-Diol (HE2100)
and Synthetic Analogue HE3204: Implications for Treatment of Autoimmune Diseases: D Auci
F Nicoletti
K Mangano
R Pieters
S Nierkens
L Morgan
H Offner
J Frincke
and C Reading. 76. Immunomodulatory Effects of Intravenous Immunoglobulins as a Treatment for Autoimmune Diseases
Cancer
and Recurrent Pregnancy Loss: Tal Sapir
Miri Blank
and Yehuda Shoenfeld. 77. Response of Vasculitic Peripheral Neuropathy to Intravenous Immunoglobulin: Yair Levy
Yosef Uziel
Giesele Zandman
Pnina Rotman
Hawared Amital
Yaniv Sherer
Pnina Langevitz
Boleck Goldman
and Yehuda Shoenfeld. 78. Involvement of Innate Immunity in the Development of Inflammatory and Autoimmune Diseases: Helena Tlaskalová-Hogenová
Ludmila Tucková
Renata Stepánková
Tomás Hudcovic
Lenka Palová-Jelínková
Hana Kozáková
Pavel Rossmann
Daniel Sanchez
Jana Cinová
Tomás Hrncír
Miloslav Kverka
Lenka Frolová
Holm Uhlig
Fiona Powrie
and Paul Bland. 79. Do We Need New Treatment That Goes beyond Tumor Necrosis Factor Blockers for Rheumatoid Arthritis?: Reinhard E. Voll and Joachim R. Kalden